Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE - Université de Rennes Access content directly
Journal Articles European Urology Year : 2015

Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE

Abstract

Referred to by Matteo Santoni, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Alberto Briganti, Francesco Montorsi, Rodolfo Montironi, Daniele Santini Re: Idir Ouzaid and Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. Eur Urol 2015;68:542–3 European Urology, Available online 1 October 2015

Domains

Bioengineering
Fichier principal
Vignette du fichier
Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE.pdf (96.59 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01260239 , version 1 (04-02-2016)

Identifiers

Cite

Idir Ouzaid, Karim Bensalah. Results of the First Trial Assessing Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Do Not reASSURE. European Urology, 2015, 68 (3), pp.542--543. ⟨10.1016/j.eururo.2015.04.042⟩. ⟨hal-01260239⟩
114 View
201 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More